Litigation Details for Scilex Pharmaceuticals, Inc. v. Aveva Drug Delivery Systems, Inc. (S.D. Fla. 2022)
✉ Email this page to a colleague
Scilex Pharmaceuticals, Inc. v. Aveva Drug Delivery Systems, Inc. (S.D. Fla. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-06-22 |
| Court | District Court, S.D. Florida | Date Terminated | 2024-08-26 |
| Cause | 35:0271 Patent Infringement | Assigned To | William P. Dimitrouleas |
| Jury Demand | Plaintiff | Referred To | Patrick M. Hunt |
| Parties | AVEVA DRUG DELIVERY SYSTEMS, INC. | ||
| Patents | 9,283,174; 9,925,264; 9,931,403 | ||
| Attorneys | Sravan Tumuluri | ||
| Firms | Carey Rodriguez Greenberg O'Keefe LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Scilex Pharmaceuticals, Inc. v. Aveva Drug Delivery Systems, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Scilex Pharmaceuticals, Inc. v. Aveva Drug Delivery Systems, Inc. (S.D. Fla. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-06-22 | 1 | Complaint | expiration of U.S. Patent Nos. 9,283,174 (the “’174 patent”), 9,925,264 (the “’264 patent”), and 9,931,403… This is an action for patent infringement under the patent laws of the United States, Title…,403 (the “’403 patent”) (collectively “the Asserted Patents”). Aveva Drug Delivery Systems, Inc. notified…Asserted Patents in the event that Aveva’s ANDA Product is approved before the Asserted Patents expire… copy of the ’174 patent is attached as Exhibit A. The ’174 patent is assigned to ITOCHU | External link to document |
| 2024-04-22 | 138 | In Limine | Wands factors, U.S. Patent Nos. 9,283,174 (“’174 patent”), 9,925,264 (“’264 patent”), and 9,931,403….” (Ex. 5 (’174 Patent) at cl. 1; Ex. 6 (’403 Patent) at cl. 1; Ex. 7 (’264 Patent) at cl. 1.) Notably…9,931,403 (“’403 patent”) (collectively referred to as the “Asserted Patents”) are invalid for lack of enablement…and 14-16 of the ’174 patent, claims 1-4, 6-10, and 14-15 of the ’403 patent, and claims 1-4, 6-10… ’174 patent encompasses 1,111,176,000 “potential formulations.” Claim 1 of the ’174 patent recites | External link to document |
| 2022-09-13 | 38 | Scheduling Report - Rule 26(f)/16.1 | U.S. Patent Nos. 9,283,174, 9,925,264, and 9,931,403 (collectively “the Asserted Patents”) on June…ZTlido®”), prior to the expiration of U.S. Patent Nos. 9,283,174, 9,925,264, 9,931,403, 10,765,640, 10,… This is an action for patent infringement under the patent laws of the United States, Title… invalidity for each of the Asserted Patents, and for U.S. Patent Nos. 10,765,640, 10,765,749, and…alleged validity of the Patents-in- Suit; prior art related to the Patents-in-Suit; any Plaintiffs | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
